MolDX: Genetic Testing for Lynch Syndrome LCD
ثبت نشده
چکیده
Contract Type Contract Number Jurisdiction State(s) Noridian Healthcare Solutions, LLC A and B MAC 02101 MAC A J F Alaska Noridian Healthcare Solutions, LLC A and B MAC 02102 MAC B J F Alaska Noridian Healthcare Solutions, LLC A and B MAC 02201 MAC A J F Idaho Noridian Healthcare Solutions, LLC A and B MAC 02202 MAC B J F Idaho Noridian Healthcare Solutions, LLC A and B MAC 02301 MAC A J F Oregon Noridian Healthcare Solutions, LLC A and B MAC 02302 MAC B J F Oregon Noridian Healthcare Solutions, LLC A and B MAC 02401 MAC A J F Washington Noridian Healthcare Solutions, LLC A and B MAC 02402 MAC B J F Washington Noridian Healthcare Solutions, LLC A and B MAC 03101 MAC A J F Arizona Noridian Healthcare Solutions, LLC A and B MAC 03102 MAC B J F Arizona Noridian Healthcare Solutions, LLC A and B MAC 03201 MAC A J F Montana Noridian Healthcare Solutions, LLC A and B MAC 03202 MAC B J F Montana Noridian Healthcare Solutions, LLC A and B MAC 03301 MAC A J F North Dakota Noridian Healthcare Solutions, LLC A and B MAC 03302 MAC B J F North Dakota Noridian Healthcare Solutions, LLC A and B MAC 03401 MAC A J F South Dakota Noridian Healthcare Solutions, LLC A and B MAC 03402 MAC B J F South Dakota Noridian Healthcare Solutions, LLC A and B MAC 03501 MAC A J F Utah Noridian Healthcare Solutions, LLC A and B MAC 03502 MAC B J F Utah Noridian Healthcare Solutions, LLC A and B MAC 03601 MAC A J F Wyoming Noridian Healthcare Solutions, LLC A and B MAC 03602 MAC B J F Wyoming
منابع مشابه
MolDX: Genetic Testing for Lynch Syndrome LCD
AMA CPT / ADA CDT / AHA NUBC Copyright Statement CPT only copyright 2002-2017 American Medical Association. All Rights Reserved. CPT is a registered trademark of the American Medical Association. Applicable FARS/DFARS Apply to Government Use. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not rec...
متن کاملMedical Policy Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management
Policy Number: 670 BCBSA Reference Number: 2.04.111 NCD/LCD: Local Coverage Determination (LCD): MolDX-CDD: Decipher Prostate Cancer Classifier Assay (L35868) Local Coverage Determination (LCD): MolDX-CDD: ProlarisTM Prostate Cancer Genomic Assay (L35869) Local Coverage Determination (LCD): MolDX: Prolaris Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease (L37...
متن کاملMedical Policy Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management
Policy Number: 670 BCBSA Reference Number: 2.04.111 NCD/LCD: Local Coverage Determination (LCD): MolDX-CDD: Decipher Prostate Cancer Classifier Assay (L35868) Local Coverage Determination (LCD): MolDX-CDD: ProlarisTM Prostate Cancer Genomic Assay (L35869) Local Coverage Determination (LCD): MolDX: Prolaris Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease (L37...
متن کاملHereditary Nonpolyposis Colorectal Cancer (HNPCC)/Lynch Syndrome: Surveillance and Diagnostic strategies
Introduction: Hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) is an autosomal dominant genetic disease. The disease is caused by a mutation in one of four genes of the DNA mismatch repair system and increases the risk for various cancers, especially the uterine and colon cancers. The prevalence of this disease in the general population is about 1 in 500 and it causes about 2-3...
متن کامل